Clinical Trials on Infection, Human Immunodeficiency Virus in Mexico
Total 636 results
-
Instituto Nacional de Salud Publica, MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...UnknownHuman Immunodeficiency Virus (HIV) | Tuberculosis (TB) | Latent Tuberculosis Infection (LTI)Mexico
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLCCompletedIncidence and Prevalence of Cancer in People Living With HIV/AIDS at Cancer Centers in Latin AmericaHIV Infection | Malignant Neoplasm | Recurrent Malignant Neoplasm | Human Immunodeficiency Virus 1 PositiveMexico, Argentina, Brazil
-
ViiV HealthcareCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, Peru, Romania, Colombia, South Africa, Germany, Russian Federation, Argentina, Mexico
-
Merck Sharp & Dohme LLCRecruitingHuman Immunodeficiency Virus (HIV) InfectionUnited States, Mexico, Russian Federation, South Africa, Thailand
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Portugal, Russian Federation, Mexico, Argentina, South Africa, Puerto Rico
-
ViiV HealthcareCompletedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusMexico, Peru, Thailand, South Africa, Russian Federation, Argentina, Brazil
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, France, Germany, Canada, Spain, United Kingdom, Mexico, Italy, Argentina, Chile, South Africa, Poland
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedInfection, Human Immunodeficiency VirusUnited States, Spain, France, Germany, Italy, Russian Federation
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, Canada, Italy, Belgium, Romania
-
ViiV HealthcareGlaxoSmithKline; ShionogiCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, France, Netherlands, Spain, Taiwan, Australia, Belgium, Russian Federation, Canada, United Kingdom, Mexico, Italy, South Africa, Romania, Argentina, Hungary, Poland, Chile, Greece, Brazil
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States, France, Spain, Canada, Italy
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, France, Spain, United Kingdom, Canada, Thailand, Italy, Portugal, Russian Federation, Mexico, Argentina, South Africa, Puerto Rico
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Mexico
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedHIV Infections | Infection, Human Immunodeficiency VirusTaiwan, France, Germany, Belgium, United States, Canada, Netherlands, Spain, Korea, Republic of, Italy, Australia, United Kingdom, Russian Federation, Portugal, Argentina, South Africa, Romania, Mexico
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, China, Germany, South Africa, Russian Federation, Argentina, Brazil, Puerto Rico, Austria, Thailand, Mexico, Uganda
-
ViiV HealthcareTerminatedHIV Infection | Infection, Human Immunodeficiency Virus IUnited States, Germany, France, Canada, Spain, Italy, Portugal, United Kingdom, Denmark, Netherlands
-
ViiV HealthcareGlaxoSmithKline; PPDCompletedInfection, Human Immunodeficiency VirusUnited States, Canada, Puerto Rico
-
University of California, San DiegoCompletedSexually Transmitted Infections | Human Immunodeficiency VirusMexico
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States, Argentina, Spain, Germany, Belgium, Australia, Canada, United Kingdom, Italy, Romania, Taiwan, Russian Federation, Mexico, France, Switzerland, Peru, Poland, Portugal
-
AbbVie (prior sponsor, Abbott)CompletedHuman Immunodeficiency VirusMexico
-
University of GuadalajaraCompletedHuman Immunodeficiency VirusMexico
-
ViiV HealthcareGlaxoSmithKline; Janssen PharmaceuticalsActive, not recruitingHIV Infections | Infection, Human Immunodeficiency VirusGermany, Spain, France, United States, Canada, Australia, Korea, Republic of, Italy, South Africa, Russian Federation, Argentina, Mexico, Sweden
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus Type 1United States, France, United Kingdom, Belgium, Spain, Switzerland, Sweden, Canada, Puerto Rico, Poland
-
National Institute of CancerologíaInstituto Nacional de Enfermedades RespiratoriasCompletedKaposi Sarcoma | Human Immunodeficiency Virus | Immune Reconstitution SyndromeMexico
-
GlaxoSmithKlineCompleted
-
Mexican Emerging Infectious Diseases Clinical Research...National Institute of Allergy and Infectious Diseases (NIAID); Instituto Nacional... and other collaboratorsCompleted
-
Tibotec Pharmaceuticals, IrelandCompletedHIV Infections | HIV-1 | Human Immunodeficiency Virus Type 1United States, Australia, France, United Kingdom, Taiwan, Spain, Argentina, Portugal, Romania, South Africa, Canada, Denmark, Sweden, Netherlands, Brazil, Puerto Rico, Austria, Russian Federation, Thailand, Mexico
-
Janssen R&D IrelandCompletedHuman Immunodeficiency Virus (HIV) InfectionFrance, Ukraine, United States, Mexico, Romania, South Africa, Peru, Argentina, Puerto Rico, Russian Federation, Guatemala
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedAcquired Immunodeficiency Syndrome | HIV | Arterial InsufficiencyMexico
-
Gilead SciencesCompleted
-
National Institute of Respiratory Diseases, MexicoHospital General Dr. Manuel Gea González; National Institute of Medical Sciences... and other collaboratorsNot yet recruitingAcquired Immunodeficiency Syndrome | Cryptococcal Meningitis | Tuberculosis Infection | Histoplasmosis AIDSMexico
-
Janssen Sciences Ireland UCCompletedImmunodeficiency Virus Type 1, HumanUnited States, France, Poland, United Kingdom, Belgium, Germany, Spain, Canada, Russian Federation, Puerto Rico
-
Gilead SciencesCompletedHepatitis C | Human Immunodeficiency VirusUnited States, Puerto Rico
-
Instituto Nacional de Ciencias Medicas y Nutricion...Instituto Mexicano del Seguro Social; National Council of Science and Technology...Unknown
-
Mexican Emerging Infectious Diseases Clinical Research...National Institute of Allergy and Infectious Diseases (NIAID); Secretaria de...CompletedDengue | Chikungunya | Zika Virus Disease (Disorder)Mexico
-
Janssen Scientific Affairs, LLCCompleted
-
ViiV HealthcarePfizerActive, not recruitingHuman Immunodeficiency VirusSpain, United States, Italy, South Africa, Brazil, Mexico, Portugal, Puerto Rico, Thailand
-
Mexican Emerging Infectious Diseases Clinical Research...National Institute of Allergy and Infectious Diseases (NIAID); Coordinación...CompletedAcute Respiratory Infections | Influenza Nos or Influenza-like IllnessMexico
-
Hospital General de MexicoAbbVieCompletedVasculitis | Chronic Hepatitis cMexico
-
Instituto Nacional de Ciencias Medicas y Nutricion...Unknown
-
NovavaxInstituto Mexicano del Seguro SocialCompletedSeasonal InfluenzaMexico
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Gilead SciencesCompletedHIV | Human Immunodeficiency Virus | HIV-1United States, Puerto Rico
-
Corporacion Parc TauliInstitut de Ciències Fotòniques (ICFO); Centre de Recerca Matemàtica; Institute...RecruitingCovid19 | ARDS, HumanSpain, Mexico, Brazil
-
Klein Buendel, Inc.National Cancer Institute (NCI); Indiana University; University of New MexicoCompletedHPV | Human Papillomavirus VirusUnited States
-
GlaxoSmithKlineCompletedHepatitis A | Cytomegalovirus | Bordetella Pertussis Infection | Viral Hepatitis Vaccines | Varicella-Zoster Virus | Herpes Simplex (1 and 2)Mexico
-
Universidad Nacional Autonoma de MexicoMerck Sharp & Dohme LLC; Secretaria de Salud, MexicoUnknownHuman Papilloma VirusMexico